Telemetered heart rate and skin potential of a chronic schizophrenic patient especially during periods of hallucinations and periods of talking.

1971 ◽  
Vol 37 (3) ◽  
pp. 345-350 ◽  
Author(s):  
Fredric M. Levine ◽  
Lester Grinspoon
Keyword(s):  
Heart Rate ◽  
Schizophrenic Patient ◽  
Skin Potential ◽  
Chronic Schizophrenic ◽  
Chronic Schizophrenic Patient

A Clinical Trial of Deserpidine and Reserpine in the Treatment of the Chronic Schizophrenic

1959 ◽  
Vol 105 (441) ◽  
pp. 1112-1118
Author(s):  
G. A. Dransfield ◽  
M. W. Browne
Keyword(s):  
Clinical Trial ◽  
Side Effects ◽  
Recent Work ◽  
Schizophrenic Patient ◽  
Clinical Effect ◽  
Toxic Effects ◽  
Related Substance ◽  
Chronic Schizophrenic ◽  
Chronic Schizophrenic Patient ◽  
Present Trial

Recent work, such as that of Moore and Martin (1957), has shown that reserpine is of value in the treatment of the chronic schizophrenic patient. Attention has however been drawn to the incidence of side-effects in this form of treatment. These side-effects have limited the application of the drug and have also led to the search for a related substance, of similar clinical effect but without the troublesome toxic effects. This present trial is of a substance, deserpidine (Harmonyl, Abbott Laboratories), which it was thought would fulfil these requirements. The isolation of this alkaloid was first reported in 1955 by Stoll and Hofman, and it has subsequently been identified as 11-desmethoxy-reserpine (Harrisson, 1955) which can be represented thus:

The Shared Field: A Precursor Stage in the Development of a Psychotherapeutic Alliance with the Hospitalized Chronic Schizophrenic Patient

Psychiatry ◽  
1984 ◽  
Vol 47 (4) ◽  
pp. 324-332 ◽  
Author(s):  
Michael A. Selzer ◽  
Monica Carsky ◽  
Bruce Gilbert ◽  
William Weiss ◽  
Matthew Klein ◽  
...  
Keyword(s):  
Schizophrenic Patient ◽  
Chronic Schizophrenic ◽  
Chronic Schizophrenic Patient ◽  
Psychotherapeutic Alliance
Sign in / Sign up

Export Citation Format

Share Document